Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06087289 |
Title | A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (KANDOVA) |
Acronym | KANDOVA |
Recruitment | Active, not recruiting |
Gender | female |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Kancera AB |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | SWE | NOR | DNK |